Recent

% | $
Quotes you view appear here for quick access.

Boston Scientific Corporation Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • fortunetrader2 fortunetrader2 Aug 24, 2005 12:26 PM Flag

    This pos isn't worth $8.New lawsuits

    BSX is not going anywhere but down from here, theres nothing but bad news and knowing a few things about this company, I am sure they have a few more bombs to drop, best case scenario, FDA doesn't shut them down.
    The competition is taking over and the stent prices are falling, and patients are dying, and getting sick, and BSX is thrashing around throwing money at junk investments because they know they have no future and no pipeline, but its a waste and the debt is growing fast.
    Thats one reason insiders are still selling shares heavily.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Yes another new lawsuit check the news. Wow all this great news lowering forcasts and missing expectations.
      Debt is over $2.4 billion. Thats BILLIONS in debt, this is not including the costs to fix the FDA problems, recalls, or recent lawsuis and litigaion. $25 million attributable to our acquisition of Advanced Bionics. The remainder of the growth in our research and development spending reflects investments to enhance our clinical and regulatory infrastructure and provide additional funding for research and development on next-generation and novel technology offerings across multiple programs and divisions. our research and development expenses increased by $109 million, or 32 percent, , research and development expenses increased The increase related primarily to an increased investment of $55 million in our drug-eluting stent franchise. Advance bionics was a TOTAL WASTE OF MONEY, $25 MILLION DOWN THE TOILET. Thats just the start, all that money invested in stents and the FDA is about to remove them from the market.

    • You are ignorant of the company. It is highly profitable and will remain so even without TAXUS. Tell us about the companies that BSX wasted its money on. Bet you don't know of any.
      The debt is actually contracting and the credit ratings are up. The future of medicine is less invasive medical care. (cheaper, better in many cases) BSX makes devices that are less invasive. With the graying of the population there will be a greater demand for these types of products in the future.

      • 2 Replies to steelwheeld2
      • You are the ignorant one Debt is over $2.4 billion. Thats BILLIONS in debt, this is not including the costs to fix the FDA problems, recalls, or recent lawsuis and litigaion.
        $25 million attributable to our acquisition of Advanced Bionics. The remainder of the growth in our research and development spending reflects investments to enhance our clinical and regulatory infrastructure and provide additional funding for research and development on next-generation and novel technology offerings across multiple programs and divisions. our research and development expenses increased by $109 million, or 32 percent, , research and development expenses increased The increase related primarily to an increased investment of $55 million in our drug-eluting stent franchise.
        Advance bionics was a TOTAL WASTE OF MONEY, $25 MILLION DOWN THE TOILET. Thats just the start, all that money invested in stents and the FDA is about to remove them from the market.

      • And there is nobody else doing the less invasive thing...Have you heard of GDT, SYK, MDT,JNJ,ZMR?? The company without Taxus was a $11 stock before it went up and split. Don't kid yourself wallstreet sees this as a one trick Pony. If Taxus goes south so will BSX.

 
BSX
22.37-0.60(-2.61%)Jun 24 4:01 PMEDT